These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34109114)

  • 1. Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis.
    Pei G; Li M; Min X; Liu Q; Li D; Yang Y; Wang S; Wang X; Wang H; Cheng H; Cao S; Huang Y
    Front Oncol; 2021; 11():653988. PubMed ID: 34109114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic characteristics of early-stage multiple primary and independent primary lung adenocarcinoma patients.
    Li P; Yang R; Wang D; Wang L; Wang S; Liu C; Li J; Li L; Liu C; Tong Y; Wang Y
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e420-e426. PubMed ID: 35098658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach.
    Chang JC; Alex D; Bott M; Tan KS; Seshan V; Golden A; Sauter JL; Buonocore DJ; Vanderbilt CM; Gupta S; Desmeules P; Bodd FM; Riely GJ; Rusch VW; Jones DR; Arcila ME; Travis WD; Ladanyi M; Rekhtman N
    Clin Cancer Res; 2019 Dec; 25(23):7113-7125. PubMed ID: 31471310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases.
    Li Z; Lv H; Zhang F; Zhu Z; Guo Q; Wang M; Huang C; Guo L; Meng F; Tian Z
    PeerJ; 2024; 12():e16808. PubMed ID: 38313018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM.
    Wang X; Gong Y; Yao J; Chen Y; Li Y; Zeng Z; Lu Y; Song L
    Front Oncol; 2020; 10():614430. PubMed ID: 33552986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characteristics and immune landscape of super multiple primary lung cancer.
    Yang Z; Zhou B; Guo W; Peng Y; Tian H; Xu J; Wang S; Chen X; Hu B; Liu C; Wang Z; Li C; Gao S; He J
    EBioMedicine; 2024 Mar; 101():105019. PubMed ID: 38364701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic features and application value of next generation sequencing in the diagnosis of synchronous multifocal lung adenocarcinoma.
    Chen X; Lu J; Wu Y; Jiang X; Gu Y; Li Y; Zhao H; Jin M
    Oncol Lett; 2020 Sep; 20(3):2829-2839. PubMed ID: 32782601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual metachronous lung adenocarcinomas harboring EGFR L858R/T790M mutations: A case report.
    Pei G; Cao S; Huang Y
    Thorac Cancer; 2020 Oct; 11(10):3020-3023. PubMed ID: 32790013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next-generation sequencing reveals recurrence-associated genomic alterations in early-stage non-small cell lung cancer.
    Cho WCS; Tan KT; Ma VWS; Li JYC; Ngan RKC; Cheuk W; Yip TTC; Yang YT; Chen SJ
    Oncotarget; 2018 Nov; 9(91):36344-36357. PubMed ID: 30555633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and transcriptomic significance of multiple primary lung cancers detected by next-generation sequencing in clinical settings.
    Yao M; Chen H; Chen Z; Wang Y; Shi D; Wu D; Li W; Huang J; Chen G; Zheng Q; Ye Z; Zheng C; Yang Y
    Carcinogenesis; 2024 Jun; 45(6):387-398. PubMed ID: 38693810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: targeted sequencing improves the diagnosis of multiple synchronous lung cancers.
    Ba Y; Li H; Zhu J; Wang H; Lv H; Guo C; Sun R; Zheng J; Meng L; Shi S
    Transl Lung Cancer Res; 2023 Apr; 12(4):933-939. PubMed ID: 37197634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Origin Evaluated by Trunk and Branching Drivers and Prevalence of Mutations in Multiple Lung Tumor Nodules.
    Rodriguez EF; Tseng LH; De Marchi F; Haung J; Belchis D; Xian R; Gocke CD; Eshleman JR; Illei PB; Lin MT
    Mol Diagn Ther; 2020 Aug; 24(4):461-472. PubMed ID: 32504414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods.
    Zhang Y; Hu H; Wang R; Ye T; Pan Y; Wang L; Zhang Y; Li H; Li Y; Shen L; Yu Y; Sun Y; Chen H; Garfield D
    Ann Surg Oncol; 2014 Dec; 21(13):4369-74. PubMed ID: 25081337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival rate and prognostic factors of surgically resected clinically synchronous multiple primary non-small cell lung cancer and further differentiation from intrapulmonary metastasis.
    Xiao F; Liu D; Guo Y; Shi B; Song Z; Tian Y; Zhang Z; Liang C
    J Thorac Dis; 2017 Apr; 9(4):990-1001. PubMed ID: 28523154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma.
    Eguren-Santamaria I; Sanchez-Bayona R; Patiño-Garcia A; Gil-Bazo I; Lopez-Picazo JM
    Lung Cancer; 2018 Aug; 122():120-123. PubMed ID: 30032819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive algorithm to distinguish between MPLC and IPM in multiple lung tumors patients.
    Shao J; Wang C; Li J; Song L; Li L; Tian P; Li W
    Ann Transl Med; 2020 Sep; 8(18):1137. PubMed ID: 33240986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
    Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
    Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.